Login / Signup

HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors.

Milton J BarrosJonathan StrosbergTaymeyah Al-ToubahVictor Hugo Fonseca de JesusLais DurantCelso A MelloTiago C FelisminoLouise De BrotRodrigo G TaboadaMauro D DonadioRachel Simões Pimenta Riechelmann
Published in: Therapeutic advances in medical oncology (2023)
NCT03870399.
Keyphrases
  • neuroendocrine tumors
  • estrogen receptor
  • open label
  • breast cancer cells
  • randomized controlled trial
  • positive breast cancer
  • clinical trial